Relypsa Announces Phase 4 Study Shows Veltassa® Demonstrated Similar Efficacy and Safety Whether Given With or Without Food in Patients with Hyperkalemia
/
Date30 Aug 2016
REDWOOD CITY, Calif., Aug. 30, 2016 (GLOBE NEWSWIRE) — Relypsa, Inc. (NASDAQ:RLYP), a biopharmaceutical company, today announced that the Phase 4 TOURMALINE study, which compared... Read More →
Myriad Genetics to Present at the 2016 Morgan Stanley Global Healthcare Conference
/
Date30 Aug 2016
SALT LAKE CITY, Aug. 30, 2016 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ:MYGN) announced today that Mark C. Capone, president and CEO, Myriad Genetics, is... Read More →
2016 National Sexual Assault Conference to Unite Experts Working to End Sexual Violence, Debut Raliance's Inaugural Report on the State of Sexual Violence
/
Date30 Aug 2016
ENOLA, Pa., Aug. 30, 2016 (GLOBE NEWSWIRE) — This year’s National Sexual Assault Conference (NSAC) will be held in Washington, D.C. from August 31 to... Read More →
Karyopharm to Host Conference Call with Update on Multiple Myeloma Plans
/
Date30 Aug 2016
NEWTON, Mass., Aug. 30, 2016 (GLOBE NEWSWIRE) — Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company, today announced it will provide an overview of top-line... Read More →
Cempra to Present Solithromycin at FDA Antimicrobial Drugs Advisory Committee Meeting on November 4, 2016
/
Date30 Aug 2016
CHAPEL HILL, N.C., Aug. 30, 2016 (GLOBE NEWSWIRE) — Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs... Read More →
Protecting Your Child's Vision is Critical for Success
/
Date30 Aug 2016
PLANTATION, Fla., Aug. 30, 2016 (GLOBE NEWSWIRE) — As the school year commences, it is important that children’s vision issues are corrected as it can... Read More →
OncoMed Pharmaceuticals Completes Enrollment of Phase 2 PINNACLE Clinical Trial of Tarextumab in Small Cell Lung Cancer
/
Date30 Aug 2016
REDWOOD CITY, Calif., Aug. 30, 2016 (GLOBE NEWSWIRE) — OncoMed Pharmaceuticals Inc. (NASDAQ:OMED), a clinical development-stage biopharmaceutical company focused on discovering and developing novel anti-cancer... Read More →
Beazley expands healthcare management liability team with additions in Chicago
/
Date30 Aug 2016
CHICAGO, Aug. 30, 2016 (GLOBE NEWSWIRE) — Beazley, a leading provider of specialist healthcare management liability insurance, has expanded its team with the addition of... Read More →
Nurse Call System Market Set for Explosive Growth, to Reach Around USD 1,600.0 Million by 2020 – MarketResearchStore.Com
/
Date30 Aug 2016
Deerfield Beach, FL, Aug. 30, 2016 (GLOBE NEWSWIRE) — Zion Market Research has published a new report titled “Nurse Call System Market by Equipment Type... Read More →
Tonix Pharmaceuticals Announces Successful End-of-Phase 2 Meeting with FDA for TNX-102 SL in Post-Traumatic Stress Disorder
/
Date29 Aug 2016
Regulatory Acceptance of Phase 3 Program and Product Registration Plan Dosing in First Phase 3 Trial Expected to Commence in the First Quarter of 2017... Read More →